Four Decades for Justice
Kiran Sheffrin focuses her practice on advising clients on the tax and structuring aspects of mergers and acquisitions, spin‑offs and other divestitures, restructurings, joint ventures and financing transactions, both in the United States and in connection with cross-border transactions. Ms. Sheffrin also advises clients during the course of tax controversy with various tax authorities.
Ms. Sheffrin’s work spans many industry sectors, with significant depth in pharmaceuticals, consumer products, telecommunications and technology.
Ms. Sheffrin’s clients have included AmerisourceBergen, Anheuser‑Busch InBev, Avon, BDT, Cincinnati Bell, Conduent, DRI Capital, Eurazeo, IBM, Lindsay Goldberg, New Senior, Parker Hannifin, RELX Group, Unilever, Valvoline and Viatris.
In 2023, Ms. Sheffrin was shortlisted for the “Rising Star: Tax” award at Euromoney Legal Media Group’s Americas Women in Business Law Awards.
Ms. Sheffrin’s notable transactions include representing:
Anheuser-Busch InBev in its $123 billion acquisition of SABMiller and the $12 billion sale of SABMiller’s U.S. and global Miller-branded businesses to Molson Coors and an asset swap with Ambev in which AB InBev transferred SABMiller’s Panamanian business to Ambev and Ambev transferred its business in Colombia, Peru and Ecuador to AB InBev;
Avon in its $3.7 billion acquisition by Natura and Avon North America in its $125 million acquisition by LG Household and Healthcare;
Cincinnati Bell in its $2.9 billion acquisition by Macquarie Infrastructure, its $650 million combination with Hawaii Telecom and its $201 million acquisition of OnX Enterprise Solutions;
Conduent in the sale of its commercial vehicle operations business to Alinda Capital Partners and the sale of its U.S.-based human resource consulting and actuarial business to H.I.G. Capital;
Dentsu Aegis in its acquisition of Merkle;
DRI Capital and its affiliates in connection with DRI Healthcare Trust’s acquisition of a royalty interest in Orserdu from Eisai, its acquisition of a second royalty interest in Orserdu from Radius Health, the $210 million sale of its TZIELD royalty interest to Sanofi and two offerings of units totaling C$201.7 million;
Eurazeo in its acquisition of Scaled Agile;
Fortress in the sale of its remaining 40.5% equity interest in OneMain Holdings to an investor group led by Apollo Global Management and Värde Partners;
The Fresh Market in its $1.36 billion sale to affiliates of Apollo;
GasLog in its take‑private transaction with BlackRock’s Global Energy & Power Infrastructure Fund;
IBM in numerous transactions, including its acquisitions of the Adobe Workfront consultancy, Agile 3 solutions, BoxBoat Technologies, the technology assets from Catalogic Software, Databand.ai, McD Tech Labs from McDonald’s, Polar Security, Randori, ReaQta and Sentaca;
Lindsay Goldberg and American Securities in the $2.405 billion acquisition of AECOM’s Management Services business, as well as Lindsay Goldberg in its acquisitions of Fleetwood-Fibre Packaging & Graphics and Allpak Container;
New Senior in its $2.3 billion acquisition by Ventas;
Orbotech in its $3.4 billion sale to KLA‑Tencor;
Unilever in its $384 million acquisition of TAZO from Starbucks, its acquisition of Seventh Generation and its acquisition of Sundial Brands;
Valvoline in the $2.65 billion sale of its Global Products business to Aramco;
Viatris in its divestitures totaling $6.94 billion in value, including the $3.335 billion combination of its biosimilars portfolio with Biocon Biologics and the pending divestitures of its Over‑the‑Counter, Women’s Healthcare and Active Pharmaceutical Ingredients businesses, and in the $750 million acquisitions of Oyster Point and Famy Life Sciences, as well as Mylan in its $50 billion combination with Upjohn, a division of Pfizer, to form Viatris, its $9.9 billion acquisition of Meda, its $5.6 billion inversion acquisition of Abbott Laboratories’ non‑U.S. developed markets specialty and branded generics business, its acquisition of the non‑sterile, topicals‑focused specialty and generics business of Renaissance Acquisition Holdings for $950 million in cash at closing plus additional contingent payments of up to $50 million and its proposal to acquire Perrigo in a transaction valued at approximately $35 billion; and
Ms. Sheffrin was born in Princeton, New Jersey and grew up in Davis, California. She received a B.A. from Wesleyan University in 2010 and a J.D. magna cum laude from Brooklyn Law School in 2013, where she was an Associate Managing Editor of the Journal of International Law and a member of the Moot Court Honor Society. Following her graduation, Ms. Sheffrin served as a law clerk to the Hon. Ralph K. Winter of the U.S. Court of Appeals for the Second Circuit.
Ms. Sheffrin joined Cravath in 2014 and was elected of counsel in 2023.
Ms. Sheffrin’s clients have included AmerisourceBergen, Anheuser‑Busch InBev, Avon, BDT, Cincinnati Bell, Conduent, DRI Capital, Eurazeo, IBM, Lindsay Goldberg, New Senior, Parker Hannifin, RELX Group, Unilever, Valvoline and Viatris.
In 2023, Ms. Sheffrin was shortlisted for the “Rising Star: Tax” award at Euromoney Legal Media Group’s Americas Women in Business Law Awards.
Ms. Sheffrin’s notable transactions include representing:
Anheuser-Busch InBev in its $123 billion acquisition of SABMiller and the $12 billion sale of SABMiller’s U.S. and global Miller-branded businesses to Molson Coors and an asset swap with Ambev in which AB InBev transferred SABMiller’s Panamanian business to Ambev and Ambev transferred its business in Colombia, Peru and Ecuador to AB InBev;
Avon in its $3.7 billion acquisition by Natura and Avon North America in its $125 million acquisition by LG Household and Healthcare;
Cincinnati Bell in its $2.9 billion acquisition by Macquarie Infrastructure, its $650 million combination with Hawaii Telecom and its $201 million acquisition of OnX Enterprise Solutions;
Conduent in the sale of its commercial vehicle operations business to Alinda Capital Partners and the sale of its U.S.-based human resource consulting and actuarial business to H.I.G. Capital;
Dentsu Aegis in its acquisition of Merkle;
DRI Capital and its affiliates in connection with DRI Healthcare Trust’s acquisition of a royalty interest in Orserdu from Eisai, its acquisition of a second royalty interest in Orserdu from Radius Health, the $210 million sale of its TZIELD royalty interest to Sanofi and two offerings of units totaling C$201.7 million;
Eurazeo in its acquisition of Scaled Agile;
Fortress in the sale of its remaining 40.5% equity interest in OneMain Holdings to an investor group led by Apollo Global Management and Värde Partners;
The Fresh Market in its $1.36 billion sale to affiliates of Apollo;
GasLog in its take‑private transaction with BlackRock’s Global Energy & Power Infrastructure Fund;
IBM in numerous transactions, including its acquisitions of the Adobe Workfront consultancy, Agile 3 solutions, BoxBoat Technologies, the technology assets from Catalogic Software, Databand.ai, McD Tech Labs from McDonald’s, Polar Security, Randori, ReaQta and Sentaca;
Lindsay Goldberg and American Securities in the $2.405 billion acquisition of AECOM’s Management Services business, as well as Lindsay Goldberg in its acquisitions of Fleetwood-Fibre Packaging & Graphics and Allpak Container;
New Senior in its $2.3 billion acquisition by Ventas;
Orbotech in its $3.4 billion sale to KLA‑Tencor;
Unilever in its $384 million acquisition of TAZO from Starbucks, its acquisition of Seventh Generation and its acquisition of Sundial Brands;
Valvoline in the $2.65 billion sale of its Global Products business to Aramco;
Viatris in its divestitures totaling $6.94 billion in value, including the $3.335 billion combination of its biosimilars portfolio with Biocon Biologics and the pending divestitures of its Over‑the‑Counter, Women’s Healthcare and Active Pharmaceutical Ingredients businesses, and in the $750 million acquisitions of Oyster Point and Famy Life Sciences, as well as Mylan in its $50 billion combination with Upjohn, a division of Pfizer, to form Viatris, its $9.9 billion acquisition of Meda, its $5.6 billion inversion acquisition of Abbott Laboratories’ non‑U.S. developed markets specialty and branded generics business, its acquisition of the non‑sterile, topicals‑focused specialty and generics business of Renaissance Acquisition Holdings for $950 million in cash at closing plus additional contingent payments of up to $50 million and its proposal to acquire Perrigo in a transaction valued at approximately $35 billion; and
Ms. Sheffrin was born in Princeton, New Jersey and grew up in Davis, California. She received a B.A. from Wesleyan University in 2010 and a J.D. magna cum laude from Brooklyn Law School in 2013, where she was an Associate Managing Editor of the Journal of International Law and a member of the Moot Court Honor Society. Following her graduation, Ms. Sheffrin served as a law clerk to the Hon. Ralph K. Winter of the U.S. Court of Appeals for the Second Circuit.
Ms. Sheffrin joined Cravath in 2014 and was elected of counsel in 2023.
Deals & Cases
February 28, 2024
On February 28, 2024, Viatris Inc. (“Viatris”), a global healthcare company, and Idorsia Ltd (“Idorsia”) announced they have entered into agreements for a significant global research and development collaboration under which Viatris will receive exclusive global development and commercialization rights to two Phase 3 assets as well as the potential to add additional innovative assets in the future.
Deals & Cases
February 06, 2024
On February 6, 2024, altafiber, provider of integrated communications solutions over its fiber‑optic network to residential and business customers in Ohio, Kentucky, and Indiana, and TowerBrook Capital Partners (“TowerBrook”), the New York and London‑based international investment firm, announced that TowerBrook has agreed to acquire CBTS, a leading North American provider of IT solutions and services, from altafiber. Cravath is representing altafiber in connection with the transaction.
Deals & Cases
February 01, 2024
On February 1, 2024, DRI Healthcare Trust (“the Trust”), a global leader in providing financing to advance innovation in the life sciences industry, announced it has expanded its interest in royalties on the U.S. net sales of Omidria® by amending its existing agreement with Omeros Corporation ("Omeros") for $115 million on closing and up to $55 million in potential sales‑based milestone payments. As a result, the Trust will now receive 100% of Omeros’s royalties on the U.S. net sales of Omidria® through December 31, 2031. Cravath is representing DRI Healthcare Trust in connection with the transaction.
Deals & Cases
January 29, 2024
On January 29, 2024, Montana Technologies LLC (“Montana Technologies”) announced an agreement to form a joint venture with GE Vernova, a global leader in electrification, decarbonization, and energy solutions, to incorporate GE Vernova’s proprietary sorbent materials into systems that utilize Montana Technologies’ patented AirJoule® dehumidification, air conditioning, and atmospheric water harvesting technology. The joint venture will exclusively manufacture and supply products incorporating the combined technologies to leading original equipment manufacturers and customers in the Americas, Africa, and Australia. Cravath is representing Montana Technologies in connection with the transaction.
Deals & Cases
January 25, 2024
On January 18, 2024, IBM announced it has signed a definitive agreement to acquire application modernization capabilities from Advanced, bringing a combination of talent, tools and knowledge to enhance IBM Consulting’s mainframe application and data modernization services. Cravath is representing IBM in connection with the transaction.
Firm News
June 15, 2023
On June 15, 2023, Sarah W. Colangelo, Rebecca J. Schindel and Kiran Sheffrin have become of counsels and Aaron S. Cha and Arian Mossanenzadeh have become senior attorneys of the Firm.
Kiran Sheffrin focuses her practice on advising clients on the tax and structuring aspects of mergers and acquisitions, spin‑offs and other divestitures, restructurings, joint ventures and financing transactions, both in the United States and in connection with cross-border transactions. Ms. Sheffrin also advises clients during the course of tax controversy with various tax authorities.
Ms. Sheffrin’s work spans many industry sectors, with significant depth in pharmaceuticals, consumer products, telecommunications and technology.
Ms. Sheffrin’s clients have included AmerisourceBergen, Anheuser‑Busch InBev, Avon, BDT, Cincinnati Bell, Conduent, DRI Capital, Eurazeo, IBM, Lindsay Goldberg, New Senior, Parker Hannifin, RELX Group, Unilever, Valvoline and Viatris.
In 2023, Ms. Sheffrin was shortlisted for the “Rising Star: Tax” award at Euromoney Legal Media Group’s Americas Women in Business Law Awards.
Ms. Sheffrin’s notable transactions include representing:
Anheuser-Busch InBev in its $123 billion acquisition of SABMiller and the $12 billion sale of SABMiller’s U.S. and global Miller-branded businesses to Molson Coors and an asset swap with Ambev in which AB InBev transferred SABMiller’s Panamanian business to Ambev and Ambev transferred its business in Colombia, Peru and Ecuador to AB InBev;
Avon in its $3.7 billion acquisition by Natura and Avon North America in its $125 million acquisition by LG Household and Healthcare;
Cincinnati Bell in its $2.9 billion acquisition by Macquarie Infrastructure, its $650 million combination with Hawaii Telecom and its $201 million acquisition of OnX Enterprise Solutions;
Conduent in the sale of its commercial vehicle operations business to Alinda Capital Partners and the sale of its U.S.-based human resource consulting and actuarial business to H.I.G. Capital;
Dentsu Aegis in its acquisition of Merkle;
DRI Capital and its affiliates in connection with DRI Healthcare Trust’s acquisition of a royalty interest in Orserdu from Eisai, its acquisition of a second royalty interest in Orserdu from Radius Health, the $210 million sale of its TZIELD royalty interest to Sanofi and two offerings of units totaling C$201.7 million;
Eurazeo in its acquisition of Scaled Agile;
Fortress in the sale of its remaining 40.5% equity interest in OneMain Holdings to an investor group led by Apollo Global Management and Värde Partners;
The Fresh Market in its $1.36 billion sale to affiliates of Apollo;
GasLog in its take‑private transaction with BlackRock’s Global Energy & Power Infrastructure Fund;
IBM in numerous transactions, including its acquisitions of the Adobe Workfront consultancy, Agile 3 solutions, BoxBoat Technologies, the technology assets from Catalogic Software, Databand.ai, McD Tech Labs from McDonald’s, Polar Security, Randori, ReaQta and Sentaca;
Lindsay Goldberg and American Securities in the $2.405 billion acquisition of AECOM’s Management Services business, as well as Lindsay Goldberg in its acquisitions of Fleetwood-Fibre Packaging & Graphics and Allpak Container;
New Senior in its $2.3 billion acquisition by Ventas;
Orbotech in its $3.4 billion sale to KLA‑Tencor;
Unilever in its $384 million acquisition of TAZO from Starbucks, its acquisition of Seventh Generation and its acquisition of Sundial Brands;
Valvoline in the $2.65 billion sale of its Global Products business to Aramco;
Viatris in its divestitures totaling $6.94 billion in value, including the $3.335 billion combination of its biosimilars portfolio with Biocon Biologics and the pending divestitures of its Over‑the‑Counter, Women’s Healthcare and Active Pharmaceutical Ingredients businesses, and in the $750 million acquisitions of Oyster Point and Famy Life Sciences, as well as Mylan in its $50 billion combination with Upjohn, a division of Pfizer, to form Viatris, its $9.9 billion acquisition of Meda, its $5.6 billion inversion acquisition of Abbott Laboratories’ non‑U.S. developed markets specialty and branded generics business, its acquisition of the non‑sterile, topicals‑focused specialty and generics business of Renaissance Acquisition Holdings for $950 million in cash at closing plus additional contingent payments of up to $50 million and its proposal to acquire Perrigo in a transaction valued at approximately $35 billion; and
Ms. Sheffrin was born in Princeton, New Jersey and grew up in Davis, California. She received a B.A. from Wesleyan University in 2010 and a J.D. magna cum laude from Brooklyn Law School in 2013, where she was an Associate Managing Editor of the Journal of International Law and a member of the Moot Court Honor Society. Following her graduation, Ms. Sheffrin served as a law clerk to the Hon. Ralph K. Winter of the U.S. Court of Appeals for the Second Circuit.
Ms. Sheffrin joined Cravath in 2014 and was elected of counsel in 2023.
Ms. Sheffrin’s clients have included AmerisourceBergen, Anheuser‑Busch InBev, Avon, BDT, Cincinnati Bell, Conduent, DRI Capital, Eurazeo, IBM, Lindsay Goldberg, New Senior, Parker Hannifin, RELX Group, Unilever, Valvoline and Viatris.
In 2023, Ms. Sheffrin was shortlisted for the “Rising Star: Tax” award at Euromoney Legal Media Group’s Americas Women in Business Law Awards.
Ms. Sheffrin’s notable transactions include representing:
Anheuser-Busch InBev in its $123 billion acquisition of SABMiller and the $12 billion sale of SABMiller’s U.S. and global Miller-branded businesses to Molson Coors and an asset swap with Ambev in which AB InBev transferred SABMiller’s Panamanian business to Ambev and Ambev transferred its business in Colombia, Peru and Ecuador to AB InBev;
Avon in its $3.7 billion acquisition by Natura and Avon North America in its $125 million acquisition by LG Household and Healthcare;
Cincinnati Bell in its $2.9 billion acquisition by Macquarie Infrastructure, its $650 million combination with Hawaii Telecom and its $201 million acquisition of OnX Enterprise Solutions;
Conduent in the sale of its commercial vehicle operations business to Alinda Capital Partners and the sale of its U.S.-based human resource consulting and actuarial business to H.I.G. Capital;
Dentsu Aegis in its acquisition of Merkle;
DRI Capital and its affiliates in connection with DRI Healthcare Trust’s acquisition of a royalty interest in Orserdu from Eisai, its acquisition of a second royalty interest in Orserdu from Radius Health, the $210 million sale of its TZIELD royalty interest to Sanofi and two offerings of units totaling C$201.7 million;
Eurazeo in its acquisition of Scaled Agile;
Fortress in the sale of its remaining 40.5% equity interest in OneMain Holdings to an investor group led by Apollo Global Management and Värde Partners;
The Fresh Market in its $1.36 billion sale to affiliates of Apollo;
GasLog in its take‑private transaction with BlackRock’s Global Energy & Power Infrastructure Fund;
IBM in numerous transactions, including its acquisitions of the Adobe Workfront consultancy, Agile 3 solutions, BoxBoat Technologies, the technology assets from Catalogic Software, Databand.ai, McD Tech Labs from McDonald’s, Polar Security, Randori, ReaQta and Sentaca;
Lindsay Goldberg and American Securities in the $2.405 billion acquisition of AECOM’s Management Services business, as well as Lindsay Goldberg in its acquisitions of Fleetwood-Fibre Packaging & Graphics and Allpak Container;
New Senior in its $2.3 billion acquisition by Ventas;
Orbotech in its $3.4 billion sale to KLA‑Tencor;
Unilever in its $384 million acquisition of TAZO from Starbucks, its acquisition of Seventh Generation and its acquisition of Sundial Brands;
Valvoline in the $2.65 billion sale of its Global Products business to Aramco;
Viatris in its divestitures totaling $6.94 billion in value, including the $3.335 billion combination of its biosimilars portfolio with Biocon Biologics and the pending divestitures of its Over‑the‑Counter, Women’s Healthcare and Active Pharmaceutical Ingredients businesses, and in the $750 million acquisitions of Oyster Point and Famy Life Sciences, as well as Mylan in its $50 billion combination with Upjohn, a division of Pfizer, to form Viatris, its $9.9 billion acquisition of Meda, its $5.6 billion inversion acquisition of Abbott Laboratories’ non‑U.S. developed markets specialty and branded generics business, its acquisition of the non‑sterile, topicals‑focused specialty and generics business of Renaissance Acquisition Holdings for $950 million in cash at closing plus additional contingent payments of up to $50 million and its proposal to acquire Perrigo in a transaction valued at approximately $35 billion; and
Ms. Sheffrin was born in Princeton, New Jersey and grew up in Davis, California. She received a B.A. from Wesleyan University in 2010 and a J.D. magna cum laude from Brooklyn Law School in 2013, where she was an Associate Managing Editor of the Journal of International Law and a member of the Moot Court Honor Society. Following her graduation, Ms. Sheffrin served as a law clerk to the Hon. Ralph K. Winter of the U.S. Court of Appeals for the Second Circuit.
Ms. Sheffrin joined Cravath in 2014 and was elected of counsel in 2023.
Deals & Cases
February 28, 2024
On February 28, 2024, Viatris Inc. (“Viatris”), a global healthcare company, and Idorsia Ltd (“Idorsia”) announced they have entered into agreements for a significant global research and development collaboration under which Viatris will receive exclusive global development and commercialization rights to two Phase 3 assets as well as the potential to add additional innovative assets in the future.
Deals & Cases
February 06, 2024
On February 6, 2024, altafiber, provider of integrated communications solutions over its fiber‑optic network to residential and business customers in Ohio, Kentucky, and Indiana, and TowerBrook Capital Partners (“TowerBrook”), the New York and London‑based international investment firm, announced that TowerBrook has agreed to acquire CBTS, a leading North American provider of IT solutions and services, from altafiber. Cravath is representing altafiber in connection with the transaction.
Deals & Cases
February 01, 2024
On February 1, 2024, DRI Healthcare Trust (“the Trust”), a global leader in providing financing to advance innovation in the life sciences industry, announced it has expanded its interest in royalties on the U.S. net sales of Omidria® by amending its existing agreement with Omeros Corporation ("Omeros") for $115 million on closing and up to $55 million in potential sales‑based milestone payments. As a result, the Trust will now receive 100% of Omeros’s royalties on the U.S. net sales of Omidria® through December 31, 2031. Cravath is representing DRI Healthcare Trust in connection with the transaction.
Deals & Cases
January 29, 2024
On January 29, 2024, Montana Technologies LLC (“Montana Technologies”) announced an agreement to form a joint venture with GE Vernova, a global leader in electrification, decarbonization, and energy solutions, to incorporate GE Vernova’s proprietary sorbent materials into systems that utilize Montana Technologies’ patented AirJoule® dehumidification, air conditioning, and atmospheric water harvesting technology. The joint venture will exclusively manufacture and supply products incorporating the combined technologies to leading original equipment manufacturers and customers in the Americas, Africa, and Australia. Cravath is representing Montana Technologies in connection with the transaction.
Deals & Cases
January 25, 2024
On January 18, 2024, IBM announced it has signed a definitive agreement to acquire application modernization capabilities from Advanced, bringing a combination of talent, tools and knowledge to enhance IBM Consulting’s mainframe application and data modernization services. Cravath is representing IBM in connection with the transaction.
Firm News
June 15, 2023
On June 15, 2023, Sarah W. Colangelo, Rebecca J. Schindel and Kiran Sheffrin have become of counsels and Aaron S. Cha and Arian Mossanenzadeh have become senior attorneys of the Firm.
Celebrating 200 years of partnership. In 2019, we celebrated our bicentennial. Our history mirrors that of our nation. Integral to our story is our culture.
Attorney Advertising. ©2024 Cravath, Swaine & Moore LLP.